Digital Health Innovators – Megan Coder At Frontiers Health 2022, pharmaphorum Editor in Chief Jonah Comstock sat down with Digital Therapeutics Alliance Chief Policy Officer Megan Coder.
News Novartis sets sights on new oral MS drug after phase 3 wins Novartis' oral BTK inhibitor remibrutinib has shown efficacy in a pair of phase 3 trials in multiple sclerosis, boosting its blockbuster credentials.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
